| Gallbladder Carcinoma studied in …STUDIED_INderived56 of 56show fewer |
|---|
| → studied in | NCT05712356Phase 2 · completed A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07146646Phase 2 · recruiting Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482516Phase 3 · recruiting Evaluating Novel Therapies in ctDNA Positive GI Cancers · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780838Phase 2 · recruiting Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07282912Phase 2 · recruiting Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793253Phase 2 · not yet recruiting Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04068194Phase 1/Phase 2 · active not recruiting Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07765433Phase 2/Phase 3 · not yet recruiting Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564403Phase 2 · active not recruiting Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05285358Phase 1 · recruiting Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02151084Phase 2 · active not recruiting A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07641036Phase 1/Phase 2 · recruiting Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03257761Phase 1 · active not recruiting Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02495896Phase 1 · active not recruiting Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07556835not yet recruiting Outcomes After Liver and Biliary Resection at a High-Volume Center · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04430738Phase 2 · active not recruiting Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03768414Phase 3 · completed Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05194072Phase 1 · terminated A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06715839NA · recruiting Target-specific immunoPET Imaging of Digestive System Carcinoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04853017Phase 1 · completed A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02375880Phase 1 · completed Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder · condition mapped ALIAS · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04941287Phase 2 · active not recruiting Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789224NA · completed Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03673072Phase 3 · completed Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Incidental Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04740164NA · completed A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04183712Phase 2 · recruiting Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04931420Phase 2 · withdrawn Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05009953Phase 2 · terminated Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03201458Phase 2 · completed Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05222854active not recruiting Comprehensive Genomic Profiling Combined With Real Life Data of "The German-Registry of Incidental Gallbladder Carcinoma" · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01825603Phase 1 · completed ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05681949NA · unknown Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04072445Phase 2 · completed Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02520141Phase 2 · completed Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02333188Phase 1 · completed Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02392637Phase 2 · completed Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01643499Phase 1 · completed Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies · condition mapped ALIAS · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03267940Phase 1 · terminated Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478140Phase 2 · terminated Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery · condition mapped ALIAS · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02649712NA · completed Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01855724Phase 2 · terminated Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03702491Phase 2 · unknown Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03581435unknown A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00142480Phase 2 · completed Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02105350Phase 1 · withdrawn A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02042443Phase 2 · completed Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085410Phase 2 · terminated Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder · condition mapped ALIAS · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00361231Phase 2 · completed Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00767234terminated Permission to Collect Blood Over Time for Research · condition mapped ONTOLOGY_EXACT · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01425879Phase 2 · completed MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01267344Phase 2 · completed A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC · condition mapped ALIAS · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093222Phase 2 · completed Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma · condition mapped CURATED_BROADER · 56 trials mapped (20 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01859182Phase 2 · withdrawn Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028496Phase 1 · completed Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer · condition mapped ALIAS · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238212Phase 2 · completed S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma · condition mapped ALIAS · 56 trials mapped (20 active) | — | — | Gallbladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |